Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
OncoCyte Corp
OCXCurrent price
2.94 USD
-0.06 USD (-2.00%)
Last closed
3 USD
Company
oncocyte.com
ISIN
US68235C1071
Sector
Healthcare
Industry
Diagnostics & Research
Exchange
NASDAQ
Capitalization
48 148 672 USD
Yield for 12 month
-11.97 %
1Y
3Y
5Y
10Y
15Y
OCX
OncoCyte Corporation, a precision diagnostics company, focuses on development and commercialization of proprietary tests in the United States and internationally. The company is developing DetermaIO, a gene expression test that assesses the tumor microenvironment to predict response to immunotherapies; DetermaCNI, a blood-based monitoring tool for monitoring therapeutic efficacy in cancer patients; and VitaGraft, a blood-based solid organ transplantation monitoring test. It also provides testing services for biomarker discovery, assay design and development, clinical trial support, and various biomarker tests. The company has a collaboration agreement with Bio-Rad Laboratories, Inc. (Bio-Rad) to collaborate in the development and the commercialization of research use only and in vitro diagnostics kitted transplant products using Bio-Rad's ddPCR instruments and reagents. OncoCyte Corporation was incorporated in 2009 and is based in Irvine, California. Address: 15 Cushing, Irvine, CA, United States, 92618
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
4.13 USDP/E ratio
–Dividend Yield
–Current Year
+1 503 000 USD
Last Year
+958 000 USD
Current Quarter
+104 000 USD
Last Quarter
+176 000 USD
Current Year
+501 000 USD
Last Year
-18 000 USD
Current Quarter
-230 500 USD
Last Quarter
-335 000 USD
Key Figures OCX
1 year
3 years
5 years
10 years
EBITDA
-20 222 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-16.67 %
PEG Ratio
–
Return On Equity TTM
-101.76 %
Wall Street Target Price
4.13 USD
Revenue TTM
1 023 000 USD
Book Value
1.7 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-77.5 %
Dividend Yield
–
Gross Profit TTM
188 000 USD
Earnings per share
-4.28 USD
Diluted Eps TTM
-4.28 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics OCX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History OCX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:20
Payout Ratio
–
Last Split Date
25.07.2023
Dividend Date
–
Stock Valuation OCX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
41.6029
Price Sales TTM
47.0662
Enterprise Value EBITDA
-1.2504
Price Book MRQ
2.1208
Financials OCX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators OCX
For 52 weeks
2.29 USD
4.34 USD
50 Day MA
3.05 USD
Shares Short Prior Month
179 641
200 Day MA
2.96 USD
Short Ratio
7.46
Shares Short
189 327
Short Percent
1.62 %
BeatStart